Automation Upgrade at Influenza Vaccine Manufacturing Facility
This retrofit and phased expansion of an existing biotechnology facility aimed to reduce costs by increasing efficiency, increasing yield, reducing waste and increasing process automation – including multiple interfaces with manufacturing.
- Liverpool, North West England, UK
- 35 million CAD (£20 M)
- ISPE 2013 Facility of the Year Award for Equipment Innovation